Traders assign a 93% probability that no new COVID-19 variant of concern will be designated before 2027 because SARS-CoV-2 continues to evolve within established Omicron lineages without triggering major public health escalations. As of September 2026, WHO monitoring shows dominant variants under monitoring such as XFG, NB.1.8.1, and BA.3.2 circulating at stable or declining levels, with no evidence of substantially increased transmissibility, severity, or immune escape that would warrant a variant of concern label. Widespread population immunity from prior infections and vaccinations has reduced hospitalizations and test positivity rates compared with earlier years, while recent vaccine updates targeting XFG reflect incremental adaptation rather than disruptive shifts. Genomic surveillance gaps persist, yet available data through mid-2026 indicate continued low-risk evolution unlikely to produce a high-impact designation in the remaining months before 2027.